Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Galectin 3 ELISA Kit (AC2561)
Cat.#: ASET-1150
Specifications
Description Mouse Galectin 3 ELISA Kit allows for the in vitro quantitative determination of mouse Galectin 3 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 18.75 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 31.25-2000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1698 Human Copeptin ELISA Kit (AC3109) Quantitative inquiry ASET-1593 Canine Insulin ELISA Kit (AC3004) Quantitative inquiry ASET-2324 Mouse SEMA3D ELISA Kit (AC3735) Quantitative inquiry ASET-2020 Human Angiogenin ELISA Kit (AC3431) Quantitative inquiry ASET-1420 Human ALDH1A1 ELISA Kit (AC2831) Quantitative inquiry ASET-1059 Human HMT ELISA Kit (AC2470) Quantitative inquiry ASET-2178 Mouse Aldh1a7 ELISA Kit (AC3589) Quantitative inquiry ASET-1782 Mouse Dopamine Transporter ELISA Kit (AC3193) Quantitative inquiry ASET-1966 Human DAG1 ELISA Kit (AC3377) Quantitative inquiry ASET-1405 Human Thimet Oligopeptidase ELISA Kit (AC2816) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket